Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?
about
Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.Specific T-cell tolerance may be preceded by a primary response.Fine mapping of T-cell determinants of bovine beta-lactoglobulin.Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.T cell priming versus T cell tolerance induced by synthetic peptides.Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetesHoming of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice.Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice.Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens.GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.Inducing immune tolerance: a focus on Type 1 diabetes mellitus.Epitope-specific tolerance induction with an engineered immunoglobulin.GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.
P2860
Q34706913-8CCC7823-2EA0-4A10-B743-F2D08A2D224CQ35318199-07E96143-C776-4F5C-9199-BDA17C4B6450Q35507250-95EB9BE1-634D-4283-B365-19711A212295Q36304716-F69B9D5B-3439-4309-9238-9F5558B45612Q36327358-FA3B28CE-E848-4B1A-B545-D241F2E59032Q36365135-7423CF19-1E81-4EDB-AA14-1C5CEC68F2C7Q36366434-77F3ADB8-07A6-43E6-B90A-C8F22231040DQ36370946-5B656B7F-3211-4EFC-AD19-24800F96D896Q36377373-1553BD03-9885-41F1-9745-67ECB7450E81Q37248995-496C34E3-CF56-4504-8DE7-7BD0475C30ECQ37359669-309589E9-6596-417B-9EE7-8FC9B1429124Q37429227-039BF852-5A61-48B4-B1CE-6C92798EEB68Q37520366-E8D04584-43FC-475B-9A22-C129C611F3BEQ37542678-1847F8CC-2E7D-4CB0-B887-4FEE7FA1B5F7Q37612708-9C36709A-3EA2-4BF3-B33C-A1B4FB56372AQ40575836-0A464A3F-2D5D-4C85-AA01-D8B63847A5F3
P2860
Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@ast
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@en
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@nl
type
label
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@ast
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@en
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@nl
prefLabel
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@ast
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@en
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@nl
P2860
P356
P1476
Antigen-specific immunotherapy ...... T-cell-mediated autoimmunity?
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.2.437
P407
P577
1994-01-01T00:00:00Z